GT-5007

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameGT-5007
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGliatech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGliatech
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A